BioCentury
ARTICLE | Clinical News

ADXS-HPV: Completed Phase II enrollment

June 4, 2012 7:00 AM UTC

Advaxis completed enrollment of 110 women with recurrent or refractory cervical cancer in an Indian Phase II trial evaluating IV ADXS-HPV with or without cisplatin. In January, Advaxis reported interi...